Expression of WNT10B is increased in lung squamous cell carcinoma

Abstract

Abstract: Objective To detect the expression of WNT10B in lung squamous cell carcinoma and to explore the correlation with pathologic feature and prognosis. Methods We collected 75 cases tissue chips of lung squamous cell carcinoma with follow-up information from Shanghai Outdo Biotech Co., ltd. The expression of WNT10B protein was examined by immunohistochemistry. Chi-squared test was used to analyze the correlation between WNT10B expression and pathological factors. Survival analysis, log-rank test and Cox proportional hazard model were employed to analyze the relationship between WNT10B expression and prognosis of patients. Results The expression of WNT10B in cancerous tissue was significantly higher than matched adjacent non-cancerous tissue (P＜0.001). High expression of WNT10B was significantly correlated with T stage and tumor differentiation (P＜0.05). WNT10B expression was correlated with the prognosis of patients (P＜0.05) and WNT10B was an independent correlation factor for the prognosis (P＜0.05). Conclusions WNT10B is involved in the occurrence and development of lung squamous cell carcinoma and is expected to be a new tumor marker and prognosis indicator.

Key words: lung squamous cell carcinoma, tissue chips, WNT10B, prognosis, immunohistochemistry

CLC Number:

R734

LU Lin, GU Yi-xun, XU Xing-xiang, MIN Ling-feng, CHEN Yan-liang, WANG Xiao-lin, CHEN Yong. Expression of WNT10B is increased in lung squamous cell carcinoma[J]. Basic & Clinical Medicine, 2020, 40(10): 1389-1393.

References

[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 Cancers in 185 countries[J].Ca Cancer J Clin, 2018, 68: 394-424.
[2] Mitsudomi T, Kosaka T, Yatabe Y. Biological and clinical implications of EGFR mutations in lung cancer[J].Int J Clin Oncol, 2006, 11: 190-198.
[3] Tanaka T, Matsuoka M, Sutani A, et al. Frequency of and variables associated with the EGFR mutation and its subtypes[J]. Int J Cancer, 2010, 126: 651-655.
[4] Perez-Moreno P, Brambilla E, Thomas R, et al. Squa-mous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities[J]. Clin Cancer Res, 2012, 18: 2443-2451.
[5] Zeng X, Zhang Y, Xu H, et al. Secreted frizzled related protein 2 modulates epithelial-mesenchymal transition and stemness via Wnt/β-Catenin signaling in choriocarcinoma[J]. Cell Physiol Biochem, 2018, 50: 1815-1831.
[6] Abitbol S, Dahmani R, Coulouarn C, et al. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation[J]. J Hepatol, 2018, 68: 1203-1213.
[7] Wu XD, Bie QL, Zhang B, et al. Wnt10B is critical for the progression of gastric cancer[J]. Oncol Lett, 2017, 13: 4231-4237.
[8] Peng L, LIU Z, XIAO J, et al.microRNA-148a suppresses epithelial-mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/β-catenin signaling pathway[J]. Oncol Rep, 2017, 38: 301-308.
[9] Chen Y, Zeng C, Zhan Y, et al. Aberrant low expression of p85α in stromal fibroblasts promotes breast cancer cell metastasis through exosome-mediated paracrine Wnt10b[J]. Oncogene, 2017, 36: 4692-4705.
[10] 卢宇青. Wnt10a/Wnt10b及其Wnt/β-catenin通路在子宫内膜癌患者中的作用机制研究[J]. 中国医学创新, 2017, 19: 22-25.
[11] 陈刚,丁华,刁统伟,等.结直肠癌预后分子标志物WNT10B及WNT家族对结直肠癌的影响[J]. 中国现代普通外科进展, 2018, 7: 543-548.
[12] Chen H, Wang Y, Xue F. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/beta-catenin pathway[J]. Oncol Rep, 2013, 29: 507-514.

[1]	WU Kun, NIE Bo, LI Yun-tao, YANG Jin-rong, CHENG Shen-ju, LI Yan-hong, SHI Ming-xia. Peripheral blood miR-200c level predicts the occurence of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation [J]. Basic & Clinical Medicine, 2022, 42(6): 871-875.
[2]	Hatimihan· MAIMAITI, Gulikezi·MAIMAITIREXIATI, LI Yu-ting, ZHOU Chang-hui, LI Rong. Expression of CBX7 protein in cervical cancer and its clinical significance [J]. Basic & Clinical Medicine, 2022, 42(5): 721-725.
[3]	HUANG Rong, ZHANG Jian, CHE Xu. Effect of SLC4A10 expression on prognosis of patient with hepatocellular carcinoma [J]. Basic & Clinical Medicine, 2022, 42(3): 461-466.
[4]	Yang Fang LI HUI MINHU. PTTG and p21 as prognostic biomarker in radiotherapy for non-functional pituitary adenomas [J]. Basic & Clinical Medicine, 2021, 41(9): 1253-1259.
[5]	WANG Yu-qian, CHEN Ya-mei, YANG Jie, LIN Yuan, LUO Ying-ying, ZHANG Shao-sen, WU Chen. Identification and analysis of key genes in association with development and progression of adenocarcinoma at the gastroesophageal junction [J]. Basic & Clinical Medicine, 2021, 41(6): 831-836.
[6]	SI Bin, ZHANG Shu-yuan, YANG Yun-yun, CHEN Yu, ZHANG Wei-li. Association of genetic variant rs3662C＞A in the gene of p21-activated kinase 2 with risk and prognosis of stroke as well as its effect on transcription activity [J]. Basic & Clinical Medicine, 2021, 41(4): 472-478.
[7]	CHEN Zhi-gang, HONG Peng, YANG Bin, TIAN Xiao-jun, WANG Guo-liang, ZHANG Shu-dong, MA Lu-lin. Constructing a risk predictive model for recurrence following nephron-sparing surgery in the treatment of clear cell renal cell carcinoma [J]. Basic & Clinical Medicine, 2021, 41(3): 409-414.
[8]	. Advances in the role of interferon-induced proteins with tetratricopeptide repeats (TPR) in digestive system tumors [J]. Basic & Clinical Medicine, 2021, 41(11): 1662-1665.
[9]	. Pathological classification and surgical prognosis of idiopathic hyperaldosteronism [J]. Basic & Clinical Medicine, 2021, 41(10): 1481-1485.
[10]	. Correlations of MGMT promoter methylation and IDH1 mutations with the clinical prognosis of malignant glioma patients [J]. Basic & Clinical Medicine, 2021, 41(10): 1476-1480.
[11]	HU Jing-jing, TONG Jin. Exploring the long-term complications of COVID-19 and its prevention through comparison with SARS and MERS [J]. Basic & Clinical Medicine, 2020, 40(7): 887-892.
[12]	. Analysis and prognosis of advanced esophageal cancer treated by Traditional Chinese Medicine [J]. Basic & Clinical Medicine, 2020, 40(2): 182-186.
[13]	CHEN Guo-yan, FENG Xiao-bo. Inhibition of miR-621 expression promotes proliferation, migration and invasion of human gastric cancer cell lines [J]. Basic & Clinical Medicine, 2020, 40(11): 1500-1505.
[14]	. Surgical strategy for temporal lobe epilepsy caused by cavernous malformation [J]. Basic & Clinical Medicine, 2019, 39(7): 1040-1044.
[15]	. High expression of LSD1 in human rectal adenocarcinoma [J]. Basic & Clinical Medicine, 2019, 39(1): 7-10.